As observed in previous studies regarding the B cell phenotype (vide supra) [21], [22], the altered B cell homeostasis and TLR9-driven response that was reported in C/T T1D patients and in healthy controls emphasizes the potential effect of the variant prior to the clinical onset of autoimmunity in predisposed individuals. This evidence concerns the gene TLR9 and Autoimmunity.